Tranexamic Acid — The Melasma Treatment Most Dermatologists Use but Most Skincare Writers Haven’t Heard Of

 The Pigmentation Ingredient the Beauty Press Is Missing

Acid wasn’t developed as a skincare ingredient. It’s a synthetic derivative of the amino acid lysine, originally developed in the 1960s as an antifibrinolytic medication — a treatment to reduce excessive bleeding. It’s still widely used medically for surgery, heavy menstrual bleeding, trauma, and other bleeding disorders. Its use in dermatology came through observation: patients taking oral acid for bleeding disorders who also had melasma reported significant pigmentation improvement, which led dermatologists to investigate the mechanism.

The mechanism turned out to be more targeted than vitamin C, azelaic acid, or most other brightening ingredients. Acid blocks plasmin activity in the keratinocyte-melanocyte interaction — plasmin is an enzyme that, when activated by UV exposure and inflammation, signals melanocytes to produce more melanin and transfer it to surrounding keratinocytes. By inhibiting plasmin, acid reduces melanin production upstream of where most other brightening ingredients work.

Vitamin C inhibits tyrosinase (the enzyme that converts tyrosine to melanin). Azelaic acid has mild tyrosinase inhibition plus anti-inflammatory effects. Niacinamide blocks melanosome transfer from melanocytes to keratinocytes. Acid intervenes earlier in the cascade — reducing the signal that tells melanocytes to produce melanin in the first place. That’s why it’s particularly effective against melasma, which is driven by plasmin activation during UV and hormonal triggers.

The reason the beauty press barely discusses acid is partly brand new: regulatory approval for widespread topical OTC availability expanded significantly over 2023–2025, so it’s only now becoming genuinely accessible outside specialist dermatology channels. And partly because the mechanism doesn’t lend itself to easy marketing — inhibits plasmin-mediated melanocyte activation is not going on a Sephora bottle front.

The Evidence: What the Published Research Actually Shows

This is where acid moves from interesting ingredient to genuinely impressive. Multiple published clinical trials support its efficacy for melasma at meaningful magnitudes.

Kim and colleagues’ 2016 work documented significant reduction in melasma severity in patients treated with topical acid compared to control groups. Subsequent randomised controlled trials and meta-analyses have produced consistent findings: acid produces measurable improvement in melasma at 8–12 weeks of use, with meta-analyses showing roughly 50–60% improvement in melasma area and severity index scores across combined trial data.

Del Rosario and colleagues’ work comparing oral acid with placebo in melasma treatment found significant melasma reduction in the acid group, supporting the systemic use that some dermatologists prescribe for particularly stubborn cases. Topical preparations at 2–5% concentrations have shown good efficacy without the systemic considerations of oral use.

For comparison: vitamin C shows meaningful but typically smaller effects on melasma (roughly 30–40% improvement at similar timeframes). Hydroquinone at 4% remains the most potent single topical for melasma (70%+ improvement often cited) but carries significant restrictions around long-term use, ochronosis risk with extended use, and regulatory limitations. Acid sits in a sweet spot: meaningfully more effective than most non-prescription alternatives, and safer for long-term use than hydroquinone.

The Demographic Where Acid Shines

Post-pregnancy melasma

This is the group where acid often outperforms alternatives most dramatically. Pregnancy melasma is triggered by hormonal changes that activate plasmin-mediated melanocyte stimulation. After pregnancy, the pigmentation often persists for months or years even though the triggering hormones have normalised. Hydroquinone isn’t appropriate for long-term maintenance use (maximum 6-month cycles typically), and vitamin C alone often produces incomplete fading. Acid addresses the specific mechanism driving the residual pigmentation and is safe for indefinite use.

Oral contraceptive-triggered melasma

Hormonal birth control can trigger melasma through similar plasmin-mediated pathways. Women who developed melasma on OCP and don’t want to change their contraception have limited options — hydroquinone cycling plus aggressive SPF is the standard approach. Acid gives them a second ingredient that addresses the upstream mechanism and can be used alongside OCP continuation.

Fitzpatrick III–VI skin with stubborn melasma

Melasma in deeper skin tones is both more common and harder to treat. The aggressive topical treatments (hydroquinone, strong retinoids, high-percentage AHAs) that work on lighter skin carry higher risk of post-inflammatory hyperpigmentation on deeper skin. Acid is well-tolerated across skin tones and doesn’t produce the rebound hyperpigmentation that aggressive treatments sometimes trigger in Fitzpatrick V–VI skin. This makes it particularly valuable for skin of colour, where gentler but still effective is a rare combination.

Melasma plateau cases

Anyone who’s been using vitamin C, niacinamide, and azelaic acid for 6+ months without continued improvement has hit the ceiling of those mechanisms. Adding acid often restarts improvement because it addresses a different pathway the existing routine wasn’t targeting. This is the reader demographic I hear from most often — people whose routines work to a point and then stop working.

The Regulatory Evolution Worth Knowing About

Topical acid availability has expanded significantly over 2023–2025. What was previously available mostly through dermatology compounding or specialised prescriptions has become more widely sold as OTC serums from brands including SkinCeuticals, Paula’s Choice, The Ordinary, Medik8, and Naturium. Regulatory approval for topical acid in cosmetic products varies by region but has generally moved toward easier access in the US, UK, Canada, EU, and Australia over this period.

This is a genuine what changed this year story that matters. Tranexamic acid existed in dermatology for 20+ years before making it into mainstream consumer skincare, and the current moment — with multiple drugstore and mid-tier brands offering effective formulations at accessible prices — is when consumer access genuinely arrived. A reader searching for tranexamic acid skincare three years ago would have found very little. Today they can buy a clinically relevant 3% serum at a drugstore price.

What Most Articles Get Wrong

Misconception #1: Acid is the same as vitamin C.

They target pigmentation through completely different mechanisms. Vitamin C inhibits melanin synthesis at the enzyme level. Tranexamic acid inhibits the signalling that tells melanocytes to produce melanin in the first place. Using both in the same routine (vitamin C morning, tranexamic acid evening, or paired) produces additive effects. Treating them as interchangeable means losing the combined benefit.

Misconception #2: Oral acid is always better than topical.

Oral tranexamic acid has stronger evidence for severe melasma but carries systemic considerations (risk of blood clots in certain patients, contraindicated during pregnancy and with certain medications). Topical tranexamic acid delivers meaningful benefit with minimal systemic absorption and is the appropriate first-line approach for most users. Oral is reserved for severe or treatment-resistant cases, under dermatology supervision.

Misconception #3: Acid brightens all hyperpigmentation equally.

It’s most effective for melasma specifically, where plasmin activation is a documented driver. Post-inflammatory hyperpigmentation (from acne, injuries) responds to tranexamic acid but typically less dramatically than vitamin C or retinoids for that specific condition. Solar lentigines (age spots) respond modestly but not as well as to retinoids or IPL treatment. Matching the ingredient to the specific pigmentation type matters — tranexamic acid is particularly valuable for melasma, and less differentiated from other ingredients for other types.

The Acid Products Worth Buying

#1 — The Inkey List Tranexamic Acid Overnight Treatment

The Inkey List Acid Overnight Treatment at around $17 delivers 2% acid alongside supporting ingredients (vitamin C, acai extract) in a well-formulated cream base. The concentration sits at the lower end of the clinical range but is genuinely therapeutic. Excellent value entry point for first-time acid users.

Pros: Affordable, well-tolerated, appropriate concentration, good supporting formulation.
Cons: 2% is the minimum effective dose — stubborn melasma may need higher concentration.

Naturium Acid Topical Acid 5% at around $30 delivers 5% acid plus kojic acid, niacinamide, and alpha arbutin in a layered-mechanism approach. Targets multiple pigmentation pathways simultaneously. Higher concentration than most competitors, making it stronger for stubborn melasma.

Naturium Tranexamic Acid Topical Acid 5% at around $30 delivers 5% tranexamic acid plus kojic acid, niacinamide, and alpha arbutin in a layered-mechanism approach. Targets multiple pigmentation pathways simultaneously. Higher concentration than most competitors, making it stronger for stubborn melasma.

Pros: Therapeutic concentration, combines complementary brightening ingredients, mid-tier pricing.
Cons: Slight tingling for sensitive skin; supporting ingredients increase the chance of reaction in reactive users.

#3 — SkinCeuticals Discoloration Defense

SkinCeuticals Discoloration Defense at around $108 is the premium dermatologist-office-pricing option. 3% acid alongside 5% niacinamide, 1% kojic acid, and 5% HEPES (a mild exfoliant). Strong clinical backing, sophisticated formulation, high price.

Pros: Dermatologist-trusted brand, sophisticated multi-mechanism formulation, well-studied specific product.
Cons: Premium pricing that reflects brand positioning more than raw ingredient cost.

Pros: Dermatologist-trusted brand, sophisticated multi-mechanism formulation, well-studied specific product.
Cons: Premium pricing that reflects brand positioning more than raw ingredient cost.

Paula’s Choice Clinical Discoloration Repair Serum at around $56 combines tranexamic acid 3% with bakuchiol (retinol alternative), vitamin C, and licorice extract. Well-formulated, mid-premium tier, suitable for sensitive skin that doesn’t tolerate retinol but needs anti-aging plus pigmentation treatment.

Paula’s Choice Clinical Discoloration Repair Serum at around $56 combines acid 3% with bakuchiol (retinol alternative), vitamin C, and licorice extract. Well-formulated, mid-premium tier, suitable for sensitive skin that doesn’t tolerate retinol but needs anti-aging plus pigmentation treatment.

#5 — Medik8 Oxy-R Peptides

Medik8 Oxy-R Peptides at around $75 uses a bioavailable acid derivative plus supporting peptides and a proprietary delivery system. More expensive than Inkey or Naturium, but with a distinct formulation approach. Good option if tolerance of other acid products has been mixed.

Pros: Different delivery chemistry, suitable for users who’ve had variable tolerance with other tranexamic acid products.
Cons: Higher price, effect similar to cheaper alternatives for most users.

How to Integrate Acid Into Your Existing Routine

Morning

1. Gentle cleanser
2. Vitamin C serum (L-ascorbic acid, at pH below 3.5 for efficacy)
3. Moisturiser
4. SPF 50+ with iron oxides for melasma (iron oxides block visible light, which drives melasma alongside UV)

Evening

1. Gentle cleanser
2. Tranexamic acid serum or cream
3. Optional: azelaic acid 10% (compatible and additive) or niacinamide 5–10%
4. Moisturiser

Alternate evenings

1. Retinol or retinaldehyde 2–4 nights weekly (not the same nights as tranexamic acid if your skin is reactive)

Tranexamic acid is well-tolerated and compatible with nearly all other skincare actives. The main exception is that combining it with aggressive exfoliants on the same evening (AHAs, BHAs at strong concentration, retinol for sensitive users) can produce irritation that isn’t from the tranexamic acid specifically but from layered aggression. Space these across different evenings if your skin is reactive.

Practical Tips

1. Give tranexamic acid 12 weeks before judging results. Melasma responds slowly to any intervention, and tranexamic acid specifically produces incremental improvement that’s visible cumulatively. The 4-week progress is often subtle; the 12-week progress is where the results become undeniable.
2. Always pair with daily SPF 50+ containing iron oxides. Melasma is triggered by UV and visible light. Without protection, tranexamic acid treats pigmentation while new pigmentation forms, producing frustratingly slow progress. Iron oxides specifically block the visible light that drives melasma alongside UV.
3. Combine tranexamic acid with vitamin C rather than choosing between them. The two work on completely different mechanisms — combining both produces better results than either alone. Vitamin C morning, tranexamic acid evening is the standard split.
4. Don’t pick at or aggressively exfoliate melasma-affected skin. Inflammation activates the plasmin cascade that tranexamic acid is blocking. Picking, scrubbing, or using strong acids on melasma skin actively works against the ingredient’s mechanism.
5. If you’re on oral hormonal contraception, talk to your doctor before starting oral tranexamic acid. Topical use is fine. Oral tranexamic acid has interaction considerations with hormonal contraception that warrant medical discussion.
6. Photograph your skin on day 1, week 6, and week 12. Same lighting, same angle. Melasma fading is gradual enough that week-to-week changes are often invisible — the before/after comparison at 12 weeks shows real progress.
7. Discontinue oral tranexamic acid if you experience any signs of blood clotting (leg pain, swelling, chest pain). This is why oral use requires medical supervision. Topical tranexamic acid carries minimal systemic absorption and doesn’t have these concerns.
8. If you’re pregnant or planning pregnancy, stick to topical only. Topical tranexamic acid is generally considered safe in pregnancy (limited absorption), but oral use is not. Azelaic acid remains the safest combined approach for pregnancy pigmentation.

Frequently Asked Questions

What is tranexamic acid in skincare?

Acid is a synthetic derivative of the amino acid lysine, originally developed as an antifibrinolytic medication (to reduce excessive bleeding). In skincare, it’s used topically at 2–5% concentrations to treat melasma and hyperpigmentation by inhibiting plasmin-mediated melanocyte activation — reducing melanin production upstream of where most brightening ingredients act.

How long does it take tranexamic acid to work?

Visible improvement typically starts at 4–8 weeks of consistent use. Substantial improvement in melasma severity accumulates over 12 weeks. Full effect is often visible at 12–16 weeks of daily use. Results continue to accumulate if use continues.

Is tranexamic acid better than vitamin C?

Different mechanisms, better combined than compared. Vitamin C inhibits tyrosinase (melanin synthesis). Acid inhibits plasmin (the signal that triggers melanin production). Using both in the same routine produces additive effects on pigmentation. For melasma specifically, acid tends to outperform vitamin C alone.

Can I use tranexamic acid during pregnancy?

Topical acid has limited absorption and is generally considered acceptable in pregnancy with medical approval. Oral acid is not recommended during pregnancy without strong medical indication. Confirm with your OB before using during pregnancy; azelaic acid 10% is the safest first-line alternative.

What’s the best tranexamic acid product?

The Inkey List Acid Overnight Treatment at 2% offers excellent budget-tier value. Naturium’s 5% version is stronger for stubborn melasma at mid-tier pricing. SkinCeuticals Discoloration Defense is the dermatologist-trusted premium option. All three contain clinically relevant concentrations; choose based on budget and melasma severity.

Can tranexamic acid cause any side effects?

Topical acid is generally well-tolerated. Mild tingling, brief warmth, or transient redness on application are occasional but not concerning. True allergic reactions are rare. Oral acid has more significant considerations (blood clot risk in certain patients, medication interactions) and requires medical supervision.

Does tranexamic acid fade dark spots and age spots too?

Yes, but less dramatically than it fades melasma. Post-inflammatory hyperpigmentation and solar lentigines respond to acid but typically not as strongly as they respond to retinoids, vitamin C, or IPL treatment. Acid’s niche strength is melasma specifically, where it outperforms most alternatives.

References

• Kim, H. J., Moon, S. H., Cho, S. H., Lee, J. D., & Kim, H. S. (2017). Efficacy and safety of tranexamic acid in melasma: a meta-analysis and systematic review. Acta Dermato-Venereologica, 97(7), 776–781.
• Del Rosario, E., Florez-Pollack, S., Zapata, L. Jr., Hernandez, K., Tovar-Garza, A., Rodrigues, M., Hynan, L. S., & Pandya, A. G. (2018). Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma. Journal of the American Academy of Dermatology, 78(2), 363–369.
• Lee, J. H., Park, J. G., Lim, S. H., Kim, J. Y., Ahn, K. Y., Kim, M. Y., & Park, Y. M. (2006). Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial. Dermatologic Surgery, 32(5), 626–631.
• Zhang, L., Tan, W. Q., Fang, Q. Q., Zhao, W. Y., Zhao, Q. M., Gao, J., & Wang, X. W. (2018). Tranexamic acid for adults with melasma: a systematic review and meta-analysis. BioMed Research International, 2018, 1683414.
• Taraz, M., Niknam, S., & Ehsani, A. H. (2017). Tranexamic acid in treatment of melasma: a comprehensive review of clinical studies. Dermatologic Therapy, 30(3).
• Maeda, K., & Naganuma, M. (1998). Topical trans-4-aminomethylcyclohexanecarboxylic acid prevents ultraviolet radiation-induced pigmentation. Journal of Photochemistry and Photobiology B, 47(2-3), 136–141.
• Tse, T. W., & Hui, E. (2013). Tranexamic acid: an important adjuvant in the treatment of melasma. Journal of Cosmetic Dermatology, 12(1), 57–66.
• Na, J. I., Choi, S. Y., Yang, S. H., Choi, H. R., Kang, H. Y., & Park, K. C. (2013). Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. Journal of the European Academy of Dermatology and Venereology, 27(8), 1035–1039.
• Bala, H. R., Lee, S., Wong, C., Pandya, A. G., & Rodrigues, M. (2018). Oral tranexamic acid for the treatment of melasma: a review. Dermatologic Surgery, 44(6), 814–825.

Want more clean beauty guides?

Get our weekly Amazon picks and skincare tips delivered free to your inbox.

This article aims to provide valuable insights into effective treatment options for melasma, ensuring readers are well-informed about various ingredients in skincare.

Subscribe Free →

Medical Disclaimer

This is editorial content, not medical advice. Melasma and hyperpigmentation treatment, particularly resistant cases, benefit from dermatological evaluation to confirm diagnosis and rule out conditions that mimic melasma. Oral tranexamic acid has medical considerations (blood clot risk, contraindications with certain conditions and medications) and should only be prescribed under medical supervision. Topical tranexamic acid is well-tolerated for most users but may cause irritation in sensitive skin.

Affiliate Disclosure

Glow Guide Reviews is an Amazon Associate. We earn from qualifying purchases at no cost to you. Product recommendations in this article are editorially independent and based on published clinical research, concentration analysis, and hands-on use. No brand paid for placement or had editorial input.